
Edwards Lifesciences Corporation EW
$ 86.51
-1.18%
Quarterly report 2026-Q1
added 05-06-2026
Edwards Lifesciences Corporation Operating Cycle 2011-2026 | EW
Annual Operating Cycle Edwards Lifesciences Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 341 | 371 | 383 | 454 | 262 | 288 | 260 | 289 | 281 | 233 | 251 | 224 | 274 | 274 | 264 | 165 | 75.9 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 454 | 75.9 | 276 |
Quarterly Operating Cycle Edwards Lifesciences Corporation
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 343 | 339 | 374 | - | 420 | 423 | 390 | - | 421 | 388 | 290 | - | 158 | 145 | 264 | - | 262 | 249 | 285 | 39.4 | 302 | 358 | 291 | 42.2 | 248 | 243 | 294 | 41.1 | 289 | 265 | 270 | 45.1 | 286 | 286 | 242 | 48.7 | 233 | 229 | 234 | 44.5 | 262 | 246 | 262 | 45.1 | 210 | 231 | 244 | 53.6 | 280 | 286 | 282 | 57.8 | 297 | 262 | 261 | 70.8 | 264 | 254 | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 423 | 39.4 | 240 |
Operating Cycle of other stocks in the Medical devices industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
159 | - | - | $ 1.77 B | ||
|
Avinger
AVGR
|
381 | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
321 | - | - | $ 3.31 B | ||
|
Eargo
EAR
|
156 | - | - | $ 10.2 M | ||
|
Lianluo Smart Limited
LLIT
|
128 | - | 24.59 % | $ 44.8 M | ||
|
Allied Healthcare Products
AHPI
|
294 | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
194 | - | -5.86 % | $ 30.6 M | ||
|
ClearPoint Neuro
CLPT
|
250 | $ 11.5 | -2.71 % | $ 326 M | ||
|
Apollo Endosurgery
APEN
|
220 | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
314 | $ 7.83 | -2.85 % | $ 1.18 B | ||
|
Aziyo Biologics
AZYO
|
205 | - | 1.37 % | $ 20.5 M | ||
|
EDAP TMS S.A.
EDAP
|
267 | $ 4.1 | -4.87 % | $ 154 M | ||
|
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
196 | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
216 | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
254 | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
789 | $ 2.24 | -2.61 % | $ 49.4 M | ||
|
CryoLife, Inc.
CRY
|
212 | - | -4.14 % | $ 702 M | ||
|
IRIDEX Corporation
IRIX
|
69.4 | $ 1.03 | -0.96 % | $ 17.4 M | ||
|
Cytosorbents Corporation
CTSO
|
212 | $ 0.49 | 6.42 % | $ 30.5 M | ||
|
OrthoPediatrics Corp.
KIDS
|
793 | $ 17.55 | -1.96 % | $ 412 M | ||
|
Delcath Systems
DCTH
|
314 | $ 10.91 | 0.74 % | $ 391 M | ||
|
Soliton, Inc.
SOLY
|
455 | - | -1.42 % | $ 435 M | ||
|
LENSAR
LNSR
|
231 | $ 5.86 | -3.14 % | $ 70.1 M | ||
|
Pulmonx Corporation
LUNG
|
307 | $ 1.54 | -1.91 % | $ 62.7 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | ||
|
LivaNova PLC
LIVN
|
181 | $ 73.9 | -2.02 % | $ 4.03 B | ||
|
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
130 | - | - | $ 111 M | ||
|
Dynatronics Corporation
DYNT
|
133 | - | 14.99 % | $ 929 K | ||
|
Myomo
MYO
|
117 | $ 1.0 | -2.91 % | $ 41.9 M | ||
|
MiMedx Group
MDXG
|
180 | $ 3.61 | -1.63 % | $ 534 M | ||
|
Electromed
ELMD
|
228 | $ 38.26 | -0.1 % | $ 323 M | ||
|
Orthofix Medical
OFIX
|
318 | $ 9.32 | -4.61 % | $ 369 M | ||
|
Butterfly Network
BFLY
|
554 | $ 4.68 | 3.08 % | $ 1.16 B | ||
|
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
224 | - | -0.97 % | $ 54.4 M | ||
|
Profound Medical Corp.
PROF
|
706 | $ 6.87 | 1.48 % | $ 208 M | ||
|
GBS
GBS
|
204 | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
347 | $ 82.54 | -3.01 % | $ 11.2 B | ||
|
Insulet Corporation
PODD
|
210 | $ 146.01 | -5.07 % | $ 10.3 B | ||
|
Sintx Technologies
SINT
|
502 | $ 2.29 | -5.76 % | $ 6.35 M | ||
|
CONMED Corporation
CNMD
|
270 | $ 35.48 | -1.61 % | $ 1.1 B | ||
|
Inspire Medical Systems
INSP
|
351 | $ 42.22 | 0.55 % | $ 1.24 B | ||
|
Integer Holdings Corporation
ITGR
|
126 | $ 88.97 | -1.3 % | $ 3.09 B | ||
|
Invacare Corporation
IVC
|
289 | - | - | $ 24.7 M | ||
|
TransMedics Group
TMDX
|
127 | $ 70.15 | -0.44 % | $ 2.38 B |